UQCRC2 and Alzheimer disease: Interestingly, the up-regulation of proteins involved in the above-mentioned pathways (i.e., Ndufab1, Sdhb, Uqcrc2) in our PS19 mice exposed to fasudil treatment highlight its promising potential by targeting these molecular signatures of AD pathogenesis.